- Home
- TAK vs VEEV Comparison
TAK vs VEEV Comparison
Compare TAK & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- VEEV
- Stock Information
- Founded
- TAK 1781
- VEEV 2007
- Country
- TAK Japan
- VEEV United States
- Employees
- TAK N/A
- VEEV N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- VEEV Computer Software: Prepackaged Software
- Sector
- TAK Health Care
- VEEV Technology
- Exchange
- TAK Nasdaq
- VEEV Nasdaq
- Market Cap
- TAK 47.3B
- VEEV 48.0B
- IPO Year
- TAK N/A
- VEEV 2013
- Fundamental
- Price
- TAK $15.16
- VEEV $269.78
- Analyst Decision
- TAK
- VEEV Buy
- Analyst Count
- TAK 0
- VEEV 28
- Target Price
- TAK N/A
- VEEV $293.82
- AVG Volume (30 Days)
- TAK 3.1M
- VEEV 1.3M
- Earning Date
- TAK 10-30-2025
- VEEV 08-27-2025
- Dividend Yield
- TAK 3.58%
- VEEV N/A
- EPS Growth
- TAK N/A
- VEEV 29.60
- EPS
- TAK 0.59
- VEEV 4.86
- Revenue
- TAK $31,053,301,865.00
- VEEV $2,968,217,000.00
- Revenue This Year
- TAK $0.40
- VEEV $15.12
- Revenue Next Year
- TAK $0.83
- VEEV $11.35
- P/E Ratio
- TAK $25.64
- VEEV $55.54
- Revenue Growth
- TAK 1.52
- VEEV 15.33
- 52 Week Low
- TAK $12.80
- VEEV $200.30
- 52 Week High
- TAK $15.56
- VEEV $296.72
- Technical
- Relative Strength Index (RSI)
- TAK 57.04
- VEEV 40.35
- Support Level
- TAK $14.90
- VEEV $280.00
- Resistance Level
- TAK $15.53
- VEEV $296.02
- Average True Range (ATR)
- TAK 0.13
- VEEV 7.03
- MACD
- TAK 0.01
- VEEV -1.51
- Stochastic Oscillator
- TAK 53.98
- VEEV 16.75
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About VEEV Veeva Systems Inc.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.